News

Alerts, news releases, and position papers to keep you in the know.

MEMBERS: KEEP UP ON THE LATEST BEHAVIORAL HEALTHCARE NEWS!

Access CEO Updates

News & Insights

Bowman Family Foundation Report: Equitable Access to Mental Health and Substance Use Care

Letters

CSOO Letter: Due Process Continuity of Care Act

Letters

NABH Letter on IPF PPS Proposed Rule

Alerts

CMS Coverage for PHP Telehealth Services Set to End After May 11

As the COVID-19 Public Health Emergency (PHE) draws to a close at the end of Thursday, May 11, the Centers for Medicare & Medicaid Services (CMS) has shared with NABH and other stakeholders the agency’s plans to end telehealth coverage for partial hospitalization program (PHP) services implemented during the PHE. In addition, CMS has explained […]

Resources

DEA Extends COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications for Now

The U.S. Drug Enforcement Administration (DEA) on Wednesday said it will extend its COVID-19 telemedicine flexibilities for prescription of controlled medications as the agency works to determine how to move forward in a way that gives Americans access to needed medicine with the appropriate safeguards. An announcement from DEA noted the agency received a record […]

Resources

CMS PHE Fact Sheet

Resources

NABH Education & Research Foundation Webpage Now Features Grants & Funding Opportunities

The NABH Research and Education Foundation has updated its webpage with a section devoted to potential funding resources and opportunities for behavioral healthcare organizations and their employees.

Resources

CBO Report: Budgetary Effects of Modifying or Eliminating the IMD Exclusion

Position Papers

NABH Contingency Management Fact Sheet

Letters

NABH Letter to DEA Telehealth Schedule II Telemedicine

Resources

2023 NABH Advocacy Priorities

Alerts

FDA Approves First Over-the-Counter Naloxone Spray

The U.S. Food and Drug Administration (FDA) today approved Narcan, 4 mg. naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use, making it the first naloxone product approved to use without a prescription. Naloxone is a medication that reverses the effects of opioid overdose rapidly and is the standard treatment for opioid overdose. The FDA’s […]

Letters

NABH Letter to Norcross-Markey

Letters

NABH Response- Senate HELP Workforce RFI

Resources

Amicus Brief: Wit v. UBH (3-17-23)

Letters

NABH FTC Non-Compete Comment Letter

Letters

NABH Prior Authorization Comment Letter

Letters

HALO Letter on Medicaid DSH Cuts March 2023

Alerts

DEA Telehealth Proposed Rules

Letters

CY 2024 MA Proposed Rule Comments

Letters

NABH OTP Comment Letter

Alerts

President Biden to Outline Approach for Addressing Nation’s Mental Health & Opioid Crises in State of the Union

In tonight’s State of the Union address, President Biden is expected to mention specific ways his administration will address America’s mental health crisis, beat its opioid overdose epidemic, and ensure parity. In a fact sheet about the speech, “mental health” is mentioned 32 times, and “fentanyl” 23 times, signaling the Biden’s administration commitment to tackling […]

Alerts

NABH Education and Research Foundation Partners with Manatt to Produce Issue Brief on Telehealth Services in PHP and IOP

NABH is pleased to announce that the NABH Education and Research Foundation today released an issue brief that shows how telehealth services effectively augment traditional partial hospitalization programs (PHP) and intensive outpatient programs (IOP). The telehealth issue brief is the first resource from the NABH Education and Research Foundation, which worked with NABH members and […]

Letters

NABH Comments on Benefit and Payment Parameters for 2024

Letters

NABH Submits Comment Letter on Federal and State Health Exchange Proposed Rule for 2024

Letters

Joint Letter to ONDCP on Contingency Management

Alerts

SAMHSA Proposed Rule Permits Methadone Prescribing for New Patients via Telemedicine

The Substance Abuse and Mental Health Services Administration (SAMHSA) on Tuesday proposed updating federal regulations to permit using audio-visual telehealth services for any new patient treated with methadone in an Opioid Treatment Program (OTP) under specific conditions. In a proposed rule, SAMHSA said federal regulations should be updated to allow using audio-visual telehealth services for […]

Alerts

Biden Administration Launches Opioid Overdose Dashboard

The Biden Administration on Thursday unveiled a new website featuring the Office of National Drug Control Policy’s (ONDCP) new Opioid Overdose Tracker to track non-fatal, opioid overdoses in the pre-hospital setting in an effort to prevent overdose deaths.

Letters

CSOO Due Process Continuity of Care Act Letter

Letters

Medicare Mobile Crisis Support Letter

Letters

Senate Letter on Enhancing the Mental Health Workforce

Letters

NABH CY2023 OPPS Comment Letter

News Releases

Rochelle Archuleta Joins NABH as Executive Vice President for Government Relations and Public Policy

Rochelle Archuleta has joined the National Association for Behavioral Healthcare (NABH) as executive vice president for government relations and public policy, effective Sept. 6.

Letters

NABH Comment Letter: Physician Fee Schedule ’23 Proposed Rule

Letters

National Sign-on Letter: 988

Resources

CMS RFI- Medicare Advantage

Letters

Letter to Secretary Becerra on ASPR

Resources

CEO Alliance for Mental Health Unified Vision 2022

Letters

Letter to Sen. Schumer on DOL-CMP Authority for MHPAEA

Alerts

NABH’s Enhanced Denial-of-Care Portal is Now Available!

The National Association for Behavioral Healthcare is pleased to announce enhancements to its Denial-of-Care Portal that are intended to make the portal easier for members to use.

News

Alerts, news releases, and position papers to keep you in the know.

MEMBERS: KEEP UP ON THE LATEST BEHAVIORAL HEALTHCARE NEWS!

Alcoholism & Drug Abuse Weekly – Dec. 16, 2024

NABH Urges CMS to Strengthen Medicaid Parity Regulations

Dan Schwartz Joins NABH as Director of Quality and Addiction Services

NABH Responds to The New York Times story on Opioid Treatment Programs

NABH MOTAA Letter to House Senate Leadership – Dec. 2024

NABH Letter to CMS on Accrediting Organizations

NABH Letter to The Joint Commission-April 2024

NABH BHIT Letter to ONC and SAMHSA

NABH 2024 Advocacy Priorities

2024 Annual Meeting At-a-Glance

MOTAA – NABH Letter

SAMHSA Updates OTP Regulations

NABH Comments on Medicare Advantage

NABH Comment Letter- Medicaid & CHIP Parity

NABH Letter on SUPPORT Act Reauthorization

NABH Letter to Senate HELP Committee on MOTAA

NABH Parity Comment Letter

NABH Urges Lawmakers to Reauthorize the SUPPORT Act

NABH Comments-OPPS PFS CY 24 Proposed Rule

9th Circuit Order-Wit-August 2023

Andrew Dodson Joins NABH as Director of Congressional Affairs

CMS Final Rule Estimates Overall IPF Payments to Increase by 2.3% in 2024

HHS, DOL and Treasury Release Proposed Rules to Strengthen MHPAEA

Bowman Family Foundation Report: Equitable Access to Mental Health and Substance Use Care

CSOO Letter: Due Process Continuity of Care Act

NABH Letter on IPF PPS Proposed Rule

CMS Coverage for PHP Telehealth Services Set to End After May 11

DEA Extends COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications for Now

CMS PHE Fact Sheet

NABH Education & Research Foundation Webpage Now Features Grants & Funding Opportunities

CBO Report: Budgetary Effects of Modifying or Eliminating the IMD Exclusion

NABH Contingency Management Fact Sheet

NABH Letter to DEA Telehealth Schedule II Telemedicine

2023 NABH Advocacy Priorities

FDA Approves First Over-the-Counter Naloxone Spray

NABH Letter to Norcross-Markey

NABH Response- Senate HELP Workforce RFI

Amicus Brief: Wit v. UBH (3-17-23)

NABH FTC Non-Compete Comment Letter

NABH Prior Authorization Comment Letter

HALO Letter on Medicaid DSH Cuts March 2023

DEA Telehealth Proposed Rules

CY 2024 MA Proposed Rule Comments

NABH OTP Comment Letter

President Biden to Outline Approach for Addressing Nation’s Mental Health & Opioid Crises in State of the Union

NABH Education and Research Foundation Partners with Manatt to Produce Issue Brief on Telehealth Services in PHP and IOP

NABH Comments on Benefit and Payment Parameters for 2024

NABH Submits Comment Letter on Federal and State Health Exchange Proposed Rule for 2024

Joint Letter to ONDCP on Contingency Management

SAMHSA Proposed Rule Permits Methadone Prescribing for New Patients via Telemedicine

Biden Administration Launches Opioid Overdose Dashboard

CSOO Due Process Continuity of Care Act Letter

Medicare Mobile Crisis Support Letter

Senate Letter on Enhancing the Mental Health Workforce

NABH CY2023 OPPS Comment Letter

Rochelle Archuleta Joins NABH as Executive Vice President for Government Relations and Public Policy

NABH Comment Letter: Physician Fee Schedule ’23 Proposed Rule

National Sign-on Letter: 988

CMS RFI- Medicare Advantage

Letter to Secretary Becerra on ASPR

CEO Alliance for Mental Health Unified Vision 2022

Letter to Sen. Schumer on DOL-CMP Authority for MHPAEA

NABH’s Enhanced Denial-of-Care Portal is Now Available!